Concepedia

Publication | Open Access

Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome

DOIFull Paper Access

83

Citations

23

References

2018

Year

Heather M. O’Leary, Walter E. Kaufmann, Katherine V. Barnes, Kshitiz Rakesh, Kush Kapur, Daniel Tarquinio, Nicole G. Cantwell, Katherine J. Roche, Suzanne Rose, Alexandra C. Walco,
Annals of Clinical and Translational Neurology

Abstract

As in the phase 1 trial, rhIGF-1 was safe; however, the drug did not reveal significant improvement, and some parameters worsened.

References

YearCitations

Page 1